Novabay Pharmaceuticals Reports Preliminary Revenue Results for the Second Quarter and First Half of 2024
For the first half of 2024, the company reported net revenue of $5.0 million, primarily derived from the Company?s eyecare products.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | +4.48% |
|
+8.37% | -67.37% |
1st Jan change | Capi. | |
---|---|---|
-67.37% | 2.68M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |